tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nicole Germino, 22 are a BUY (88%), 3 are a HOLD (12%).
Analyst Nicole Germino, currently employed at TRUIST, carries an average stock price target met ratio of 42.36% that have a potential upside of 67.39% achieved within 172 days.
Nicole Germino’s has documented 46 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 21-Feb-2025.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 5/16/2024. The price target of $48 was fulfilled within 12 days with a profit of $22.9 (91.24%) receiving and performance score of 76.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 months 2 days ago
(24-Mar-2025)
0/1 (0%)
$-9.98 (-79.97%)
7 months 6 days ago
(20-Sep-2024)
3/3 (100%)
$-28.44 (-48.67%)
621
Buy
$14
$3.3 (30.84%)
$14
2 years 5 months 10 days ago
(16-Nov-2022)
4/4 (100%)
$-1.84 (-11.62%)
328
Buy
$11
$0.3 (2.80%)
$12
2 years 6 months 2 days ago
(24-Oct-2022)
5/5 (100%)
$-8.2 (-42.71%)
307
Buy
$12
$-1.72 (-12.54%)
$15
3 years 25 days ago
(01-Apr-2022)
2/2 (100%)
$-12.72 (-51.46%)
502
Which stock is Nicole Germino is most bullish on?
Which stock is Nicole Germino is most reserved on?
What Year was the first public recommendation made by Nicole Germino?
